,X,Filing Date,Trade Date,Ticker,Insider Name,Title,Trade Type,Price,Qty,Owned,ΔOwn,Value,1d,1w,1m,6m,ticker
0,,2020-09-24 16:25:42,2020-09-22,AKCA,Patterson Joshua F.,GC,S - Sale,$18.12,-319,26532,-1%,"-$5,780",,,,,AKCA
1,,2020-09-24 16:21:08,2020-09-22,AKCA,Jenne Kyle,Chief Commercial Officer,S - Sale,$18.12,-720,52012,-1%,"-$13,046",,,,,AKCA
2,,2020-09-24 16:19:25,2020-09-22,AKCA,McDevitt Damien,CEO,S - Sale,$18.12,-8709,242978,-3%,"-$157,807",,,,,AKCA
3,,2020-09-02 16:20:43,2020-08-31,AKCA,McDevitt Damien,CEO,A - Grant,$14.40,1104,251687,0%,"+$15,896",,,,,AKCA
4,,2020-07-20 17:18:34,2020-07-17,AKCA,Patterson Joshua F.,GC,S - Sale,$12.50,-263,26851,-1%,"-$3,288",,,,,AKCA
5,D,2020-07-10 17:31:41,2020-07-09,AKCA,Andrews William T.,Chief Medical Officer,A - Grant,$0.00,37500,37500,New,+$0,,,,,AKCA
6,D,2020-05-19 17:41:35,2020-05-18,AKCA,Price Michael Dennis,CFO,A - Grant,$0.00,50000,50000,New,+$0,,,,,AKCA
7,,2020-04-15 17:30:58,2020-04-15,AKCA,Patterson Joshua F.,GC,A - Grant,$0.00,12500,27114,+86%,+$0,,,,,AKCA
8,AD,2020-03-31 20:41:34,2020-03-19,AKCA,McDevitt Damien,CEO,A - Grant,$0.00,60000,260000,+30%,+$0,,,,,AKCA
9,,2020-03-25 16:44:27,2020-03-23,AKCA,Patterson Joshua F.,GC,S - Sale,$11.76,-335,14614,-2%,"-$3,938",,,,,AKCA
10,,2020-03-25 16:43:31,2020-03-23,AKCA,Jenne Kyle,Chief Commercial Officer,S - Sale,$11.75,-779,52732,-1%,"-$9,153",,,,,AKCA
11,,2020-03-25 16:42:29,2020-03-23,AKCA,O'Dea Louis,Chief Medical Officer,S - Sale,$11.75,-3198,61602,-5%,"-$37,579",,,,,AKCA
12,,2020-03-25 16:41:05,2020-03-23,AKCA,McDevitt Damien,CEO,S - Sale,$11.75,-9417,245783,-4%,"-$110,649",,,,,AKCA
13,D,2020-03-23 16:35:58,2020-03-19,AKCA,Howarth Alex G.,COO,A - Grant,$0.00,16800,66800,+34%,+$0,,,,,AKCA
14,D,2020-03-23 16:34:03,2020-03-19,AKCA,Jenne Kyle,Chief Commercial Officer,A - Grant,$0.00,16800,53511,+46%,+$0,,,,,AKCA
15,D,2020-03-23 16:32:05,2020-03-19,AKCA,O'Dea Louis,Chief Medical Officer,A - Grant,$0.00,16800,64800,+35%,+$0,,,,,AKCA
16,D,2020-03-23 16:29:19,2020-03-19,AKCA,Patterson Joshua F.,GC,A - Grant,$0.00,3780,14949,+34%,+$0,,,,,AKCA
17,D,2020-03-23 16:22:25,2020-03-19,AKCA,McDevitt Damien,CEO,A - Grant,$0.00,55200,255200,+28%,+$0,,,,,AKCA
18,,2020-01-16 18:05:48,2020-01-15,AKCA,O'Dea Louis,Chief Medical Officer,A - Grant,$0.00,28000,48000,+140%,+$0,,,,,AKCA
19,,2020-01-16 18:03:09,2020-01-15,AKCA,Maclean Michael F,CFO,A - Grant,$0.00,28000,48000,+140%,+$0,,,,,AKCA
20,D,2019-12-04 16:08:26,2019-12-02,AKCA,Howarth Alex G.,COO,A - Grant,$0.00,50000,50000,New,+$0,,,,,AKCA
21,D,2019-10-23 16:21:49,2019-10-21,AKCA,Jenne Kyle,Chief Commercial Officer,A - Grant,$0.00,25000,36711,+213%,+$0,,,,,AKCA
22,D,2019-09-30 21:26:09,2019-09-26,AKCA,Goldberg Jeff Marc,COO,M - OptEx,$6.96,421432,156631,-159%,"+$2,932,747",,,,,AKCA
23,D,2019-09-30 21:26:09,2019-09-26,AKCA,Goldberg Jeff Marc,COO,F - Tax,$16.64,-268111,156631,-63%,"-$4,461,367",,,,,AKCA
24,D,2019-09-30 17:52:33,2019-09-26,AKCA,Soteropoulos Paula,CEO,M - OptEx,$7.05,2061861,678149,-149%,"+$14,538,254",,,,,AKCA
25,D,2019-09-30 17:52:33,2019-09-26,AKCA,Soteropoulos Paula,CEO,F - Tax,$16.64,-1383712,678149,-67%,"-$23,024,968",,,,,AKCA
26,,2019-09-23 19:22:52,2019-09-19,AKCA,O'Dea Louis,Chief Medical Officer,A - Grant,$0.00,20000,20000,New,+$0,,,,,AKCA
27,,2019-09-23 17:24:55,2019-09-19,AKCA,Maclean Michael F,CFO,A - Grant,$0.00,20000,20000,New,+$0,,,,,AKCA
28,D,2019-09-23 17:22:17,2019-09-19,AKCA,McDevitt Damien,Interim Chief Exec Office,A - Grant,$0.00,200000,200000,New,+$0,,,,,AKCA
29,,2019-07-17 16:52:30,2019-07-15,AKCA,Boyce Sarah,Pres,S - Sale,$23.52,-1819,19888,-8%,"-$42,783",,,,,AKCA
30,,2019-07-03 16:31:19,2019-07-01,AKCA,Boyce Sarah,Pres,A - Grant,$20.04,813,21707,+4%,"+$16,295",,,,,AKCA
31,,2019-07-03 16:28:12,2019-07-01,AKCA,Goldberg Jeff Marc,COO,A - Grant,$20.04,430,3310,+15%,"+$8,618",,,,,AKCA
32,DM,2019-04-09 19:00:38,2019-04-05,AKCA,Goldberg Jeff Marc,COO,S - Sale+OE,$31.71,-50000,2880,-95%,"-$1,585,718",,,,,AKCA
33,DM,2019-04-09 19:00:38,2019-04-05,AKCA,Goldberg Jeff Marc,COO,M - OptEx,$6.48,50000,2880,-106%,"+$324,000",,,,,AKCA
34,DM,2019-04-09 18:59:06,2019-04-05,AKCA,Soteropoulos Paula,CEO,S - Sale+OE,$32.11,-31787,0,-100%,"-$1,020,780",,,,,AKCA
35,DM,2019-04-09 18:59:06,2019-04-05,AKCA,Soteropoulos Paula,CEO,M - OptEx,$6.48,31787,0,-100%,"+$205,980",,,,,AKCA
36,D,2019-03-07 17:20:44,2019-03-06,AKCA,Soteropoulos Paula,CEO,S - Sale+OE,$32.14,-18386,0,-100%,"-$590,856",,,,,AKCA
37,D,2019-03-07 17:20:44,2019-03-06,AKCA,Soteropoulos Paula,CEO,M - OptEx,$6.48,18386,0,-100%,"+$119,141",,,,,AKCA
38,,2018-04-19 18:48:19,2018-04-17,AKCA,Ionis Pharmaceuticals Inc,10%,P - Purchase,$18.75,10666666,64114545,+20%,"+$199,999,988",,,,,AKCA
39,D,2018-04-18 13:00:19,2018-04-17,AKCA,Boyce Sarah,Pres,A - Grant,$0.00,20894,20894,New,+$0,,,,,AKCA
40,D,2017-07-21 16:04:26,2017-07-19,AKCA,Ionis Pharmaceuticals Inc,10%,C - Converted deriv,$0.00,28884540,45447879,-39%,$0,,,,,AKCA
41,D,2017-07-21 16:04:26,2017-07-19,AKCA,Ionis Pharmaceuticals Inc,10%,P - Purchase,$8.00,3125000,45447879,+7%,"+$25,000,000",,,,,AKCA
